Madrigal Pharmaceuticals
-$0.52 (-0.78%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MDGL and other ETFs, options, and stocks.
About MDGL
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia.
CEO
Paul A. Friedman
Employees
71
Headquarters
West Conshohocken, Pennsylvania
Founded
2011
MDGL Key Statistics
Market cap
1.13B
Price-Earnings ratio
—
Dividend yield
—
Average volume
184.68K
High today
$67.64
Low today
$65.00
Open price
$67.40
Volume
106.15K
52 Week high
$131.92
52 Week low
$52.33
Analyst ratings
92%
of 12 ratings
Buy
91.7%
Hold
0%
Sell
8.3%
MDGL Earnings
-$3.90
-$2.60
-$1.30
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$3.62 per share
Actual
-$3.36 per share